Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 8.89 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 11.5 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 10.7 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 10.3 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 8.14 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 7.41 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 9.86 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 9.58 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 0.0 | BCD100427B001 | 3.08 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 0.5 | BCD100427B003 | 2.6 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 1.0 | BCD100427B007 | 9.42 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 2.0 | BCD100427B011 | 17.6 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 4.0 | BCD100427B015 | 4.98 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 8.0 | BCD100427B019 | 21 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 12.0 | BCD100427B023 | 6.28 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 24.0 | BCD100427B027 | 11.9 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 31.2 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 20.2 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 10.7 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 11.2 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 10.8 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 15.8 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 12.9 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 0.5 | BCD100427B004 | 2.18 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 1.0 | BCD100427B008 | 5.77 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 2.0 | BCD100427B012 | 14 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 4.0 | BCD100427B016 | 4.65 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 8.0 | BCD100427B020 | 8.72 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 12.0 | BCD100427B024 | 14 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 24.0 | BCD100427B028 | 7.8 | pmol/ug DNA |